These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 28300015
21. Divergent Features of Mitochondrial Deficiencies in LGMD2A Associated With Novel Calpain-3 Mutations. El-Khoury R, Traboulsi S, Hamad T, Lamaa M, Sawaya R, Ahdab-Barmada M. J Neuropathol Exp Neurol; 2019 Jan 01; 78(1):88-98. PubMed ID: 30500922 [Abstract] [Full Text] [Related]
22. Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Kramerova I, Beckmann JS, Spencer MJ. Biochim Biophys Acta; 2007 Feb 01; 1772(2):128-44. PubMed ID: 16934440 [Abstract] [Full Text] [Related]
24. Allosteric Modulation of GSK-3β as a New Therapeutic Approach in Limb Girdle Muscular Dystrophy R1 Calpain 3-Related. Rico A, Guembelzu G, Palomo V, Martínez A, Aiastui A, Casas-Fraile L, Valls A, López de Munain A, Sáenz A. Int J Mol Sci; 2021 Jul 08; 22(14):. PubMed ID: 34298987 [Abstract] [Full Text] [Related]
26. Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype? Pizzanelli C, Mancuso M, Galli R, Choub A, Fanin M, Nascimbeni AC, Siciliano G, Murri L. Neurol Sci; 2006 Jun 08; 27(2):134-6. PubMed ID: 16816913 [Abstract] [Full Text] [Related]
27. C3KO mouse expression analysis: downregulation of the muscular dystrophy Ky protein and alterations in muscle aging. Jaka O, Kramerova I, Azpitarte M, López de Munain A, Spencer M, Sáenz A. Neurogenetics; 2012 Nov 08; 13(4):347-57. PubMed ID: 22820870 [Abstract] [Full Text] [Related]
28. Epidemiological and Molecular Characterization of a Mexican Population Isolate with High Prevalence of Limb-Girdle Muscular Dystrophy Type 2A Due to a Novel Calpain-3 Mutation. Pantoja-Melendez CA, Miranda-Duarte A, Roque-Ramirez B, Zenteno JC. PLoS One; 2017 Nov 08; 12(1):e0170280. PubMed ID: 28103310 [Abstract] [Full Text] [Related]
29. Limb-Girdle Muscular Dystrophy Type 2A Resulting From c.C479G and c.G1818A Mutations in the Calpain-3 Gene. Ramos E, Pardo S, Mas Rodríguez MF, Vélez J. J Clin Neuromuscul Dis; 2015 Dec 08; 17(2):59-62. PubMed ID: 26583491 [Abstract] [Full Text] [Related]
30. Involvement of oxidative stress, nuclear factor kappa B and the ubiquitin proteasomal pathway in dysferlinopathy. Rajakumar D, Senguttuvan S, Alexander M, Oommen A. Life Sci; 2014 Jul 11; 108(1):54-61. PubMed ID: 24846833 [Abstract] [Full Text] [Related]
31. Translocation of molecular chaperones to the titin springs is common in skeletal myopathy patients and affects sarcomere function. Unger A, Beckendorf L, Böhme P, Kley R, von Frieling-Salewsky M, Lochmüller H, Schröder R, Fürst DO, Vorgerd M, Linke WA. Acta Neuropathol Commun; 2017 Sep 15; 5(1):72. PubMed ID: 28915917 [Abstract] [Full Text] [Related]
32. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: The yield and the pitfalls. Fanin M, Angelini C. Muscle Nerve; 2015 Aug 15; 52(2):163-73. PubMed ID: 25900067 [Abstract] [Full Text] [Related]
33. A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene. Matsubara E, Tsuchiya A, Minami N, Nishino I, Pappolla MA, Shoji M, Abe K. Eur J Neurol; 2007 Jul 15; 14(7):819-22. PubMed ID: 17594342 [Abstract] [Full Text] [Related]
34. NF-kappaB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A. Benayoun B, Baghdiguian S, Lajmanovich A, Bartoli M, Daniele N, Gicquel E, Bourg N, Raynaud F, Pasquier MA, Suel L, Lochmuller H, Lefranc G, Richard I. FASEB J; 2008 May 15; 22(5):1521-9. PubMed ID: 18073330 [Abstract] [Full Text] [Related]
35. Mutations of CAPN3 in Korean patients with limb-girdle muscular dystrophy. Shin JH, Kim HS, Lee CH, Kim CM, Park KH, Kim DS. J Korean Med Sci; 2007 Jun 15; 22(3):463-9. PubMed ID: 17596655 [Abstract] [Full Text] [Related]
36. A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice. Barzilai-Tutsch H, Dewulf M, Lamaze C, Butler Browne G, Pines M, Halevy O. Hum Mol Genet; 2018 Aug 15; 27(16):2817-2829. PubMed ID: 29771357 [Abstract] [Full Text] [Related]
37. In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs. Blázquez L, Aiastui A, Goicoechea M, Martins de Araujo M, Avril A, Beley C, García L, Valcárcel J, Fortes P, López de Munain A. Hum Mutat; 2013 Oct 15; 34(10):1387-95. PubMed ID: 23864287 [Abstract] [Full Text] [Related]
38. Effect of cyclic stretch on beta1D-integrin expression and activation of FAK and RhoA. Zhang SJ, Truskey GA, Kraus WE. Am J Physiol Cell Physiol; 2007 Jun 15; 292(6):C2057-69. PubMed ID: 17267546 [Abstract] [Full Text] [Related]
39. Limb-girdle muscular dystrophy 2A. Gallardo E, Saenz A, Illa I. Handb Clin Neurol; 2011 Jun 15; 101():97-110. PubMed ID: 21496626 [Abstract] [Full Text] [Related]
40. beta1D integrin inhibits cell cycle progression in normal myoblasts and fibroblasts. Belkin AM, Retta SF. J Biol Chem; 1998 Jun 12; 273(24):15234-40. PubMed ID: 9614138 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]